ScottES, McGrathRT, JanuszewskiAS, et al.: HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment. BMJ Open, 2019; 9:e033059.
2.
FosterNC, BeckRW, MillerKM, et al.: State of type 1 diabetes management and outcomes from the T1D exchange in 2016–2018. Diabetes Technol Ther, 2019; 21:66–72.
3.
ForlenzaGP: Use of artificial intelligence to improve diabetes outcomes in patients using multiple daily injections therapy. Diabetes Technol Ther, 2019; 21(S2):S24–S28.
4.
SherrJ, BuckinghamBA, ForlenzaG, et al.: Safety and performance of the Omnipod hybrid closed-loop system in adults, adolescents, and children with type 1 diabetes over 5 days under free-living conditions. Diabetes Technol Ther, 2020; 22:174–184.
5.
ContrerasI, VehiJ: Artificial intelligence for diabetes management and decision support: literature review. J Med Internet Res, 2018; 20:e10775.
6.
MillerKM, FosterNC, BeckRW, et al.: Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D exchange clinic registry. Diabetes Care, 2015; 38:971–978.
7.
HaidarA, FaridD, St-YvesA, et al.: Post-breakfast closed-loop glucose control is improved when accompanied with carbohydrate-matching bolus compared to weight-dependent bolus. Diabetes Metab, 2014; 40:211–214.
8.
de BockM, McAuleySA, AbrahamMB, et al.: Effect of 6 months hybrid closed-loop insulin delivery in young people with type 1 diabetes: a randomised controlled trial protocol. BMJ Open, 2018; 8:e020275.
9.
HaidarA: The artificial pancreas: how closed-loop control is revolutionizing diabetes. IEEE Control Systems Magazine, 2016; 36:28–47.
10.
BekiariE, KitsiosK, ThabitH, et al.: Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis. BMJ, 2018; 361:k1310.
11.
SeoW, LeeYB, LeeS, et al.: A machine-learning approach to predict postprandial hypoglycemia. BMC Med Inform Decis Mak, 2019; 19:210.
12.
HajizadehI, HobbsN, SamadiS, et al.: Controlling the AP controller: controller performance assessment and modification. J Diabetes Sci Technol, 2019; 13:1091–1104.
13.
PalisaitisE, El FathiAE, Von OettingenJE, et al.: The efficacy of basal rate and carbohydrate ratio learning algorithm for closed-loop insulin delivery (artificial pancreas) in youth with type 1 diabetes in a diabetes camp. Diabetes Technol Ther, 2020; 22:185–194.
14.
NimriR, DassauE, SegallT, et al.: Adjusting insulin doses in patients with type 1 diabetes who use insulin pump and continuous glucose monitoring: variations among countries and physicians. Diabetes Obes Metab, 2018; 20:2458–2466.
15.
Children and Adolescents: Standards of Medical Care in Diabetes-2020. Diabetes Care, 2020; 43(Supplement 1):S163–S182.
16.
EkhlaspourL, ForlenzaGP, ChernavvskyD, et al.: Closed loop control in adolescents and children during winter sports: use of the tandem control-IQ AP system. Pediatr Diabetes, 2019; 20:759–768.
17.
BretonMD, ChernavvskyDR, ForlenzaGP, et al.: Closed loop control during intense prolonged outdoor exercise in adolescents with type 1 diabetes: the artificial pancreas ski study. Diabetes Care, 2017; 40:1644–1650.
18.
DeBoerMD, BretonMD, WakemanC, et al.: Performance of an artificial pancreas system for young children with type 1 diabetes. Diabetes Technol Ther, 2017; 19:293–298.
19.
RenardE, Tubiana-RufiN, Bonnemaison-GilbertE, et al.: Closed-loop driven by control-to-range algorithm outperforms threshold-low-glucose-suspend insulin delivery on glucose control albeit not on nocturnal hypoglycaemia in prepubertal patients with type 1 diabetes in a supervised hotel setting. Diabetes Obes Metab, 2019; 21:183–187.
20.
MesserLH, BergetC, ForlenzaGP: A clinical guide to advanced diabetes devices and closed-loop systems using the CARES paradigm. Diabetes Technol Ther, 2019; 21:462–469.
21.
WoldaregayAZ, ArsandE, WalderhaugS, et al.: Data-driven modeling and prediction of blood glucose dynamics: machine learning applications in type 1 diabetes. Artif Intell Med, 2019; 98:109–134.
22.
WangY, ZhangJ, ZengF, et al.: “Learning” can improve the blood glucose control performance for type 1 diabetes mellitus. Diabetes Technol Ther, 2017; 19:41–48.
23.
ResalatN, HiltsW, YoussefJE, et al.: Adaptive control of an artificial pancreas using model identification, adaptive postprandial insulin delivery, and heart rate and accelerometry as control inputs. J Diabetes Sci Technol, 2019; 13:1044–1053.
24.
GargSK, WeinzimerSA, TamborlaneWV, et al.: Glucose outcomes with the in-home use of a hybrid closed-loop insulin delivery system in adolescents and adults with type 1 diabetes. Diabetes Technol Ther, 2017; 19:155–163.
25.
Fegan-BohmK, Weissberg-BenchellJ, DeSalvoD, et al.: Camp for youth with type 1 diabetes. Curr Diab Rep, 2016; 16:68.
26.
ShiD, DassauE, DoyleFJ, 3rd.: Multivariate learning framework for long-term adaptation in the artificial pancreas. Bioeng Transl Med, 2019; 4:61–74.
27.
CinarA: Multivariable adaptive artificial pancreas system in type 1 diabetes. Curr Diab Rep, 2017; 17:88.
28.
KavakiotisI, TsaveO, SalifoglouA, et al.: Machine learning and data mining methods in diabetes research. Comput Struct Biotechnol J, 2017; 15:104–116.
29.
KovatchevB: Automated closed-loop control of diabetes: the artificial pancreas. Bioelectron Med, 2018; 4:14.
